Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.48 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.47 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.47 |
| ▸ | MAOB | P27338 | 1/20 | 0.46 |
| ▸ | CASR | P41180 | 1/20 | 0.45 |
| ▸ | CA4 | P22748 | 1/20 | 0.45 |
| ▸ | MTNR1A | P48039 | 3/20 | 0.44 |
| ▸ | MTNR1B | P49286 | 3/20 | 0.44 |
| ▸ | ACHE | P22303 | 1/20 | 0.42 |
| ▸ | PGR | P06401 | 1/20 | 0.42 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.42 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26042904 | 0.94 | TAAR1 (0.51) | ALDH1A1TAAR1SLC6A2SLC6A4MTNR1A | |
| SCHEMBL8160360 | 0.87 | TAAR1 (0.44) | ALDH1A1TAAR1SLC6A2SLC6A4MTNR1A | |
| SCHEMBL13408672 | 0.83 | CA4 (0.50) | ALDH1A1SLC6A2SLC6A4CA4PGR | |
| SCHEMBL23509837 | 0.82 | SLC6A2 (0.42) | ALDH1A1SLC6A2SLC6A4CASRCA4 | |
| SCHEMBL14940633 | 0.79 | TAAR1 (0.48) | ALDH1A1TAAR1MTNR1AMTNR1BACHE | |
| SCHEMBL21999768 | 0.79 | CA4 (0.45) | ALDH1A1SLC6A2SLC6A4CA4PGR | |
| SCHEMBL19049724 | 0.79 | CA4 (0.45) | ALDH1A1SLC6A2SLC6A4CA4PGR | |
| SCHEMBL13338728 | 0.78 | ACHE (0.47) | ALDH1A1ACHEHSD17B1HSD17B2 | |
| Isopropyldiphenylamine SCHEMBL27697074 | 0.78 | ALDH1A1 (0.50) | ALDH1A1TAAR1 | |
| Isopropyldiphenylamine SCHEMBL2119054 | 0.78 | ALDH1A1 (0.50) | ALDH1A1TAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100108997-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2010-05-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100108997-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | OR10J3, OCIAD1, OCIAD2 | ALDH1A1 428/4885TAAR1 1913/4885SLC6A2 2141/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.